miR-29b-3p targetedly regulates VEGF to inhibit tumor progression and cisplatin resistance through Nrf2/HO-1 signaling pathway in non-small cell lung cancer.
Sun Z, Ren M, Niu J, Tang G, Li Y, Kong F, Song X. Environ Toxicol. 2024 Jul; 39(7):3956-3966. Epub 2024 Apr 8.